Evidence map›Paper›PMID 41511723›Full record

ReviewMolecular and cellular biochemistry2026

Advances in natural compounds modulating autophagy for the therapeutic intervention of heart failure.

Jiaqian Tang, Chang Zhou, Mengyuan Li, Jing Tao, Ruying Deng, Xinyi Ouyang, Guomin Zhang, Huiping Liu

Abstract readReview
In one paragraph

Review in Molecular and cellular biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jiaqian Tang *College of Integrative Medicine, Hunan University of Traditional Chinese Medicine, 300 Bachelor Street, Changsha, 410208, Hunan, P.R. China.
Chang Zhou *College of Integrative Medicine, Hunan University of Traditional Chinese Medicine, 300 Bachelor Street, Changsha, 410208, Hunan, P.R. China.
Mengyuan Li *College of Integrative Medicine, Hunan University of Traditional Chinese Medicine, 300 Bachelor Street, Changsha, 410208, Hunan, P.R. China.
Jing TaoCollege of Integrative Medicine, Hunan University of Traditional Chinese Medicine, 300 Bachelor Street, Changsha, 410208, Hunan, P.R. China.
Ruying DengCollege of Integrative Medicine, Hunan University of Traditional Chinese Medicine, 300 Bachelor Street, Changsha, 410208, Hunan, P.R. China.
Xinyi OuyangCollege of Integrative Medicine, Hunan University of Traditional Chinese Medicine, 300 Bachelor Street, Changsha, 410208, Hunan, P.R. China.
Guomin ZhangCollege of Integrative Medicine, Hunan University of Traditional Chinese Medicine, 300 Bachelor Street, Changsha, 410208, Hunan, P.R. China. 003334@hnucm.edu.cn.
Huiping LiuCollege of Integrative Medicine, Hunan University of Traditional Chinese Medicine, 300 Bachelor Street, Changsha, 410208, Hunan, P.R. China. 003433@hnucm.edu.cn.

Funding

National College Students Innovation and Entrepreneurship Training Program X202510541003Natural Science Foundation of Hunan Province 2024JJ9466Natural Science Foundation of Hunan Province 2025JJ90014Science and Technology Program of Hunan Province kzd22005
6 · The paper itself

Abstract

Heart failure (HF) represents the terminal stage of multiple cardiovascular disorders and is characterized by substantial morbidity, disability, and mortality. Although standard pharmacotherapies offer partial symptomatic relief, their capacity to halt or reverse disease progression remains limited. In recent years, autophagy-an essential intracellular degradation and recycling process that safeguards cardiomyocyte homeostasis-has emerged as a critical determinant in the onset and progression of HF. In this review, we systematically examined approximately 170 research articles related to "natural compounds-autophagy-HF" published up to 2025, and synthesized major advances reported over the past five years. Based on chemical structure and natural source, representative bioactive compounds were categorized into five major classes: flavonoids, polyphenols, alkaloids, terpenoids, and marine-derived molecules. We then integrated evidence on the principal autophagy-regulatory signaling cascades influenced by these compounds, including the AMP-activated protein kinase (AMPK)/mechanistic target of rapamycin (mTOR) axis, phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt), sirtuin 1 (SIRT1)/forkhead box O (FOXO), BCL2/adenovirus E1B 19 kDa-interacting protein 3 (BNIP3)/NIP3-like protein X (NIX), and Beclin-1 pathways. Moreover, this review summarizes how these natural compounds modulate autophagy to attenuate key pathological processes associated with HF, including cardiac hypertrophy, adverse ventricular remodeling, mitochondrial dysfunction, and cardiomyocyte apoptosis. By comparing convergent mechanisms and compound-specific differences in autophagy-mediated cardioprotection, we highlight emerging mechanistic patterns and therapeutic implications. Collectively, through structured classification of compounds, integration of autophagy signaling pathways, and assessment of translational potential, this review provides a systematic framework to guide the rational application and further development of natural products for the prevention and treatment of HF.

Indexed as

AutophagyBiological ProductsHeart FailureAnimalsHumansMyocytes, CardiacSignal TransductionBiological ProductsAutophagyHeart failureMyocardial protectionNatural compoundsSignal pathway

Identifiers

PMID41511723
PMCPMC12996028

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.